ATAGI advice on the use of Bexsero® vaccine

Australian Technical Advisory Group on Immunisation (ATAGI) advice for immunisation providers on the use of Bexsero®.

Downloads

ATAGI advice on the use of Bexsero® vaccine

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Last updated:
Publication type:
Guideline
Audience:
Health sector
Language:
English
Description:

This document contains Australian Technical Advisory Group on Immunisation (ATAGI) advice for immunisation providers about the use of Bexsero®, a recombinant multicomponent meningococcal B vaccine (4CMenB).

It includes information about transport, storage and handling, dosage and administration, recommendations, contraindications, adverse events and references to more detailed information.

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.